Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Second Uniqueness Theorem01:16

Second Uniqueness Theorem

Consider a region consisting of several individual conductors with a definite charge density in the region between these conductors. The second uniqueness theorem states that if the total charge on each conductor and the charge density in the in-between region are known, then the electric field can be uniquely determined.
In contrast, consider that the electric field is non-unique and apply Gauss's law in divergence form in the region between the conductors and the integral form to the surface...
Catalytically Perfect Enzymes01:07

Catalytically Perfect Enzymes

The theory of catalytically perfect enzymes was first proposed by W.J. Albery and J. R. Knowles in 1976. These enzymes catalyze biochemical reactions at high-speed. Their catalytic efficiency values range from 108-109 M-1s-1. These enzymes are also called 'diffusion-controlled' as the only rate-limiting step in the catalysis is that of the substrate diffusion into the active site. Examples include triose phosphate isomerase, fumarase, and superoxide dismutase.
Superconductor01:24

Superconductor

A substance that reaches superconductivity, a state in which magnetic fields cannot penetrate, and there is no electrical resistance, is referred to as a superconductor. In 1911, Heike Kamerlingh Onnes of Leiden University, a Dutch physicist, observed a relation between the temperature and the resistance of the element mercury. The mercury sample was then cooled in liquid helium to study the linear dependence of resistance on temperature. It was observed that, as the temperature decreased, the...
Nuclear Overhauser Enhancement (NOE)01:06

Nuclear Overhauser Enhancement (NOE)

Irradiation of a spin-active nucleus causes an increase or decrease in the signal intensity of neighboring nuclei that are not necessarily chemically bonded or involved in J-coupling. This phenomenon, called the nuclear Overhauser enhancement (NOE), results from through-space interactions between the nuclear spins. The NOE effect decreases with increasing internuclear distance and is generally not observed beyond 4 angstroms. In NOE, dipole-dipole interactions between neighboring spin-active...
Orders of Magnitude01:15

Orders of Magnitude

The order of magnitude of a number is the power of 10 that most closely approximates it. Thus, the order of magnitude estimates the scale (or size) of its value. To find the order of magnitude of a number, take the base-10 logarithm of the number and round it to the nearest integer. Then the order of magnitude of the number is simply the resulting power of 10.
The order of magnitude is simply a way of rounding numbers consistently to the nearest power of 10. This makes doing rough mental math...
Ranks01:02

Ranks

Unlike parametric methods, nonparametric statistics are ideal for nominal and ordinal data, requiring fewer assumptions about the population's nature or distribution. This makes nonparametric methods easier to apply and interpret, as they do not depend on parameters like mean or standard deviation. One common approach in nonparametric analysis is to sort data according to a specific criterion. For instance, we might arrange weather data from hottest to coldest days in a month or rank cities...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

BiTEing the Tumor.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2020
Same author

Increased Bone Marrow Plasma-Cell Percentage Predicts Outcomes in Newly Diagnosed Multiple Myeloma Patients.

Clinical lymphoma, myeloma & leukemia·2020
Same author

Deepening responses associated with improved progression-free survival with ixazomib versus placebo as posttransplant maintenance in multiple myeloma.

Leukemia·2020
Same author

Medication Shortages During the COVID-19 Crisis: What We Must Do.

Mayo Clinic proceedings·2020
Same author

A validated composite organ and hematologic response model for early assessment of treatment outcomes in light chain amyloidosis.

Blood cancer journal·2020
Same author

Multiple myeloma: 2020 update on diagnosis, risk-stratification and management.

American journal of hematology·2020
Same journal

Arterial iron regulates vasodilation during anemia via endothelial holo α-globin.

Blood·2026
Same journal

One-stage Assay Factor VIII Activity Reflects AAV-Derived Factor VIII-Enhanced Thrombin Activation and Predicts Phenotype.

Blood·2026
Same journal

NSD2 Degradation Remediates the Oncogenic Cistrome in t(4;14) Multiple Myeloma.

Blood·2026
Same journal

Menin-MLL inhibitors enhance JUND activity in MLLr leukemic cells contributing to tumorigenesis and therapy resistance.

Blood·2026
Same journal

FGF18 mediates fibroblast-leukemia crosstalk to promote acute myeloid leukemia progression.

Blood·2026
Same journal

Iron in HSCs: too much of a good thing.

Blood·2026
See all related articles

Related Experiment Video

Updated: May 19, 2026

Free Radicals in Chemical Biology: from Chemical Behavior to Biomarker Development
14:22

Free Radicals in Chemical Biology: from Chemical Behavior to Biomarker Development

Published on: April 15, 2013

Second to none.

S Vincent Rajkumar1

  • 1Mayo Clinic, USA.

Blood
|August 25, 2012
PubMed
Summary
This summary is machine-generated.

This study examined second primary malignancies in patients receiving thalidomide and lenalidomide. The findings offer crucial insights into the long-term safety of these immunomodulatory drugs.

More Related Videos

Quantification of Hydrogen Concentrations in Surface and Interface Layers and Bulk Materials through Depth Profiling with Nuclear Reaction Analysis
14:11

Quantification of Hydrogen Concentrations in Surface and Interface Layers and Bulk Materials through Depth Profiling with Nuclear Reaction Analysis

Published on: March 29, 2016

Related Experiment Videos

Last Updated: May 19, 2026

Free Radicals in Chemical Biology: from Chemical Behavior to Biomarker Development
14:22

Free Radicals in Chemical Biology: from Chemical Behavior to Biomarker Development

Published on: April 15, 2013

Quantification of Hydrogen Concentrations in Surface and Interface Layers and Bulk Materials through Depth Profiling with Nuclear Reaction Analysis
14:11

Quantification of Hydrogen Concentrations in Surface and Interface Layers and Bulk Materials through Depth Profiling with Nuclear Reaction Analysis

Published on: March 29, 2016

Area of Science:

  • Hematology
  • Oncology
  • Clinical Trials

Background:

  • Thalidomide and lenalidomide are immunomodulatory drugs used in treating multiple myeloma.
  • Understanding the long-term safety profile, particularly regarding secondary malignancies, is crucial for patient management.

Purpose of the Study:

  • To investigate the incidence and characteristics of second primary malignancies (SPMs) in patients treated with thalidomide and lenalidomide.
  • To assess the risk of SPMs within the context of the Arkansas Total Therapy Trials.

Main Methods:

  • Retrospective analysis of patient data from the Arkansas Total Therapy Trials.
  • Evaluation of treatment regimens involving thalidomide and lenalidomide.
  • Statistical analysis to determine the incidence and risk factors for SPMs.

Main Results:

  • Patients treated with thalidomide and lenalidomide showed a specific pattern of second primary malignancies.
  • The study identified key findings regarding the occurrence of SPMs in this patient cohort.

Conclusions:

  • Thalidomide and lenalidomide treatment may be associated with an increased risk of certain second primary malignancies.
  • These findings underscore the importance of long-term surveillance for SPMs in patients receiving these therapies.